Form S-3/A Dermata Therapeutics,
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Dermata Therapeutics, Inc (DRMA) files $100M mixed shelf
May 22, 2026 5:18 PM EDTDermata Therapeutics, Inc (NASDAQ: DRMA) has filed $100,000,000 mixed shelf of:
Common Stock
Preferred Stock
Warrants
Debt Securities
Subscription Rights
Units
... More